Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease
| dc.contributor.author | Rizvi, Syed Mohd. Danish | |
| dc.contributor.author | Shaikh, Sibhghatulla | |
| dc.contributor.author | Waseem, Shah Mohammad Abbas | |
| dc.contributor.author | Shakil, Shazi | |
| dc.contributor.author | Abuzenadah, Adel M. | |
| dc.contributor.author | Biswas, Deboshree | |
| dc.contributor.author | Tabrez, Shams | |
| dc.contributor.author | Ashraf, Ghulam Md. | |
| dc.contributor.author | Kamal, Mohammad Amjad | |
| dc.date.accessioned | 2016-05-20T09:14:47Z | |
| dc.date.available | 2016-05-20T09:14:47Z | |
| dc.date.issued | 2015-05-19 | |
| dc.description.abstract | Recent data have suggested a strong possible link between Type 2 Diabetes Mellitus and Alzheimer’s disease (AD), although exact mechanisms linking the two are still a matter of research and debate. Interestingly, both are diseases with high incidence and prevalence in later years of life. The link appears so strong that some scientists use Alzheimer’s and Type 3 Diabetes interchangeably. In depth study of recent data suggests that the anti diabetic drugs not only have possible role in treatment of Alzheimer’s but may also arrest the declining cognitive functions associated with it. The present review gives an insight into the possible links, existing therapeutics and clinical trials of anti diabetic drugs in patients suffering from AD primarily or as co-morbidity. It may be concluded that the possible beneficial effects and usefulness of the current anti diabetic drugs in AD cannot be neglected and further research is required to achieve positive results. Currently, several drug trials are in progress to give conclusive evidence based data. | en |
| dc.identifier.doi | 10.17179/excli2015-252 | |
| dc.identifier.issn | 1611-2156 | |
| dc.identifier.uri | http://hdl.handle.net/2003/34994 | |
| dc.identifier.uri | http://dx.doi.org/10.17877/DE290R-17042 | |
| dc.language.iso | en | |
| dc.relation.ispartofseries | EXCLI Journal;Vol. 14, 2015 | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Alzheimer’s disease | en |
| dc.subject | anti-diabetic drugs | en |
| dc.subject | amyloid beta | en |
| dc.subject | beta-secretase | en |
| dc.subject | sodium glucose | en |
| dc.subject | co-transporters | en |
| dc.subject | Type 2 Diabetes Mellitus | en |
| dc.subject.ddc | 610 | |
| dc.title | Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease | en |
| dc.type | Text | |
| dc.type.publicationtype | article | |
| dcterms.accessRights | open access | |
| eldorado.dnb.zdberstkatid | 2132560-1 |